Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Resting heart rate in cardiovascular disease.

Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Lopez Sendon JL, Steg PG, Tardif JC, Tavazzi L, Tendera M; Heart Rate Working Group..

J Am Coll Cardiol. 2007 Aug 28;50(9):823-30. Epub 2007 Aug 13. Review.

2.

Heart rate in ischemic heart disease. The innovation of ivabradine: more than pure heart rate reduction.

Rosano GM, Vitale C, Volterrani M.

Adv Ther. 2010 Apr;27(4):202-10. doi: 10.1007/s12325-010-0030-9. Epub 2010 May 20. Review.

PMID:
20495895
3.

Ivabradine: recent and potential applications in clinical practice.

Riccioni G.

Expert Opin Pharmacother. 2011 Feb;12(3):443-50. doi: 10.1517/14656566.2011.548321. Review.

PMID:
21254949
4.

Role of heart rate in cardiovascular diseases: how the results of the BEAUTIFUL study change clinical practice.

Bruguera Cortada J, Varela A.

Am J Cardiovasc Drugs. 2009;9 Suppl 1:9-12. doi: 10.2165/1153162-S0-000000000-00000. Review.

PMID:
20000882
5.

Heart rate as a treatable cardiovascular risk factor.

Tardif JC.

Br Med Bull. 2009;90:71-84. doi: 10.1093/bmb/ldp016. Epub 2009 May 27. Review.

PMID:
19474056
6.

[Heart rate, a major prognostic factor of cardiovascular risk].

Lévy S, Guize L.

Therapie. 2006 Mar-Apr;61(2):115-9. French.

PMID:
16886703
7.

[Heart rate: a risk factor or an epiphenomenon?].

Metra M, Zacà V, Lombardi C, Bugatti S, Dei Cas L.

G Ital Cardiol (Rome). 2010 Mar;11(3):209-20. Review. Italian.

PMID:
20550061
8.

Heart rate in coronary syndromes and heart failure.

Orso F, Baldasseroni S, Maggioni AP.

Prog Cardiovasc Dis. 2009 Jul-Aug;52(1):38-45. doi: 10.1016/j.pcad.2009.05.006. Review.

PMID:
19615492
10.

Effect of timolol on mortality and reinfarction after acute myocardial infarction: prognostic importance of heart rate at rest.

Gundersen T, Grøttum P, Pedersen T, Kjekshus JK.

Am J Cardiol. 1986 Jul 1;58(1):20-4.

PMID:
3524181
12.

Significance of reduction in heart rate in cardiovascular disease.

Hjalmarson A.

Clin Cardiol. 1998 Dec;21(12 Suppl 2):II3-7. Review.

13.

Long-term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction.

Björkander I, Forslund L, Ericson M, Rehnqvist N, Hjemdahl P, Kahan T.

Clin Physiol Funct Imaging. 2009 May;29(3):201-8. doi: 10.1111/j.1475-097X.2009.00857.x. Epub 2009 Mar 2.

PMID:
19254330
14.

Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: Analysis of the CARDIf Study Cohort.

Vitale C, Iellamo F, Volterrani M, Lombardi M, Fini M, Banach M, Rosano GM.

Angiology. 2010 Nov;61(8):763-7. doi: 10.1177/0003319710369102. Epub 2010 May 12.

PMID:
20462892
15.

Heart rate and cardiovascular protection.

Caetano J, Delgado Alves J.

Eur J Intern Med. 2015 May;26(4):217-22. doi: 10.1016/j.ejim.2015.02.009. Epub 2015 Feb 20. Review.

PMID:
25704330
16.

Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.

Diaz A, Bourassa MG, Guertin MC, Tardif JC.

Eur Heart J. 2005 May;26(10):967-74. Epub 2005 Mar 17.

PMID:
15774493
17.

Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.

Harris FJ, Low RI, Paumer L, Amsterdam EA, Mason DT.

Am J Cardiol. 1983 Jan 1;51(1):13-8.

PMID:
6129794
18.

What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).

Gullestad L, Wikstrand J, Deedwania P, Hjalmarson A, Egstrup K, Elkayam U, Gottlieb S, Rashkow A, Wedel H, Bermann G, Kjekshus J; MERIT-HF Study Group..

J Am Coll Cardiol. 2005 Jan 18;45(2):252-9.

19.

Ivabradine: beyond heart rate control.

Riccioni G, Vitulano N, D'Orazio N.

Adv Ther. 2009 Jan;26(1):12-24. doi: 10.1007/s12325-008-0130-y. Epub 2009 Jan 22. Review.

PMID:
19165437
20.

Resting heart rate and outcomes in patients with cardiovascular disease: where do we currently stand?

Menown IB, Davies S, Gupta S, Kalra PR, Lang CC, Morley C, Padmanabhan S.

Cardiovasc Ther. 2013 Aug;31(4):215-23. doi: 10.1111/j.1755-5922.2012.00321.x. Review.

Supplemental Content

Support Center